Prescription Required
Authentic Product
India's Leading Generic Pharmacy
Secure Payment
CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION
CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION
By CIPLA PHARMACEUTICAL COMPANY LIMITED
MRP
₹
119500
₹116150
2.8 % OFF
Check Delivery
--
Composition
Product Details
About CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION
- CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is a medication containing two active ingredients: Casirivimab and Imdevimab. These are special types of proteins called monoclonal antibodies. Think of them as lab-made antibodies designed to help your body fight off the coronavirus. This injection is primarily used to treat people who have recently tested positive for mild to moderate acute COVID-19 infection and are at high risk of their symptoms getting worse. It works by targeting the spike protein of the coronavirus, which helps prevent the virus from entering your cells and multiplying, thereby reducing the viral load in the body.
- This treatment can also serve as a preventative measure (post-exposure prophylaxis) against acute COVID-19 infection in certain individuals. This includes people who have been exposed to someone with COVID-19 or who are at high risk of developing severe illness if they contract the virus, especially if they are unable to receive a COVID-19 vaccine for medical reasons. COVID-19 is caused by the SARS-CoV-2 coronavirus and spreads easily from person to person, mainly through respiratory droplets. Administering this injection early in the disease course or shortly after exposure can significantly reduce the likelihood of severe illness, hospitalization, or death.
- Do not take CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION if you are allergic to Casirivimab, Imdevimab, or any of the other ingredients in the injection. It is vital to inform your doctor or healthcare provider about any known allergies before you receive this treatment. Allergic reactions, including serious ones, can occur during or shortly after the infusion or injection. Symptoms may include rash, itching, hives, swelling (especially of the face, lips, tongue, or throat), dizziness, feeling faint, shortness of breath, or chest tightness. You must notify your physician or nurse immediately if you experience any signs of an allergic or infusion-related reaction.
- Before receiving this injection, please inform your doctor if you have previously been vaccinated against COVID-19. Your doctor will consider your vaccination status when deciding if this treatment is appropriate for you. It is also essential to inform your doctor if you are pregnant, planning to become pregnant, or are breastfeeding. The potential risks and benefits of CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION during pregnancy or breastfeeding should be discussed with your healthcare provider to make an informed decision.
- Like any medication, CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION monoclonal antibody therapy can cause side effects. Common side effects reported include reactions at the injection or infusion site, such as pain, swelling, bruising, or redness. Other potential side effects may include fever, feeling flushed, headaches, shortness of breath, chest discomfort or tightness, nausea, and vomiting. While most side effects are mild to moderate, it's important to report any symptoms you experience to your doctor promptly. This medicine is recommended for use in individuals aged 12 years and older who weigh at least 35.5 kilograms (about 78 pounds). Its safety and effectiveness have not been evaluated in younger children or individuals below this weight threshold.
Uses of CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION
- Effective in treating and preventing acute COVID-19 infection.
Side Effects of CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. The following are potential side effects of CASIRIVIMAB IMDEVIRAB REGN-COV2 INJECTION.
Safety Advice for CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION
Pregnancy
Consult a DoctorThere is limited information on the safety of CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION during pregnancy. Inform your physician if you are pregnant, suspecting, or planning for pregnancy
Dosage of CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION
- CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is a special treatment given to help your body fight off certain infections. There are two ways you might receive it. One way is called an infusion, where the medicine is dripped slowly into a vein in your arm. This usually takes about 20 to 30 minutes. The other way is a subcutaneous injection, which means it's given just under the skin. No matter which way you get it, this injection must *always* be given by a trained healthcare professional, like a doctor or nurse. They have the right experience to give you this specific medicine safely. While you are receiving the injection and for a short time afterward, they will stay with you to make sure you are doing okay and watch for any reactions. This is why it's very important *not* to try and give yourself this medicine at home. It needs professional care and monitoring.
How to store CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION?
- Keep CASIRIVIMAB IMDEVIMAB REGN-COV2 INJ away from the reach of children and pets.
- Store CASIRIVIMAB IMDEVIMAB REGN-COV2 INJ in a refrigerator (2 - 8°C). Do not freeze.
Benefits of CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION
- This treatment uses special lab-made antibodies to attach to the coronavirus's 'spike protein,' blocking it from entering your cells.
- By preventing the virus from attaching to your cells, it helps stop the infection from spreading within your body.
- This can help reduce the amount of virus in your system, potentially leading to less severe symptoms.
- By giving your body a head start in fighting the infection, it may help you recover more quickly.
How to use CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION
- CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is administered in a controlled medical setting by a qualified healthcare professional. It can be given in two main ways: either directly into a vein through an intravenous (IV) infusion, which typically takes about 20 to 30 minutes to complete, or as an injection under the skin (subcutaneous). Your doctor or nurse will determine the best method of administration for your specific situation.
- Because this is a specialized treatment, it is crucial that it is given by someone experienced in handling such medications. During and immediately after you receive the injection or infusion, the medical staff will closely monitor you to watch for any potential reactions or side effects. This monitoring is an important safety measure. You should never attempt to inject yourself with this medicine. It is vital that the administration is performed by a trained professional in a clinical environment to ensure your safety and the effectiveness of the treatment. Please follow all instructions provided by your healthcare team regarding the administration and care.
FAQs
How effective is CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION in treating COVID-19?
Clinical studies have shown that CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION can significantly reduce the risk of hospitalization or death in high-risk individuals with COVID-19. However, the effectiveness may vary depending on individual factors, including the illness's severity and specific variants of the virus.
Can CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION be used in combination with other COVID-19 treatments?
CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION can be used alone or in combination with other COVID-19 treatments as determined by healthcare professionals. It is important to consult with healthcare providers to ensure proper coordination of treatments and minimize any potential interactions.
How soon after testing positive for COVID-19 should CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION be administered?
CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is most effective when administered early after testing positive for COVID-19, ideally within 10 days of symptom onset. Early treatment helps reduce the severity of illness and the risk of hospitalization.
Can CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION be used in pediatric patients?
Yes, CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is authorized for use in pediatric patients aged 12 years and older who weigh at least 35.5kg and are at high risk of developing severe COVID-19.
Can CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION be used as a substitute for COVID-19 vaccination?
No, CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is not a substitute for COVID-19 vaccination. Vaccination is the most effective way to prevent COVID-19 and its complications. This injection is specifically used to treat individuals who have already tested positive for the virus and are at high risk of developing the infection.
Does CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION interact with other drugs?
Information on specific drug interactions should be discussed with a healthcare professional. They can determine if CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION can be used safely with any other medications you are taking.
What are the precautions and potential side effects of CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION?
Self isolate and use infection control measures (eg, wearing mask, social distancing, avoid sharing personal items, clean and disinfecting “high touch” surfaces, and frequent handwashing). The most common side effects may include infusion-related reactions such as swelling in the hands, face, and feet, skin rash, breathing difficulties, cough, abdominal pain, and chest pain. Injection site reactions like swelling and redness at the injection site can also occur.
What are the active ingredients in CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION?
The active ingredients in CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION are Casirivimab and Imdevimab.
What is CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION used for?
CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is used as an antiviral treatment for COVID-19.
Is CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION an antiviral medication?
Yes, CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is an antiviral medication used to treat COVID-19.
References
Ratings & Review
Good representation and good communication to the cx very helpfull
Sunny Mack
•
Reviewed on 02-02-2024
(5/5)
Staf behaviour and madicine knowledge was good.
Ranjana Bhati
•
Reviewed on 13-01-2024
(5/5)
Visited medkart and it was a great experience with staff and they explains everything about generic medicine. How they r less in cost and both continent and power are same., everyone who buy their monthly medicine from other medicine stores should visit medkart and convert to generic medicine........ Best of luck medkart
Solanki Girish
•
Reviewed on 19-04-2023
(5/5)
Super
Elvis
•
Reviewed on 25-01-2024
(5/5)
Very good service and discount
Yatin Patel
•
Reviewed on 13-01-2024
(5/5)
Marketer / Manufacturer Details
CIPLA PHARMACEUTICAL COMPANY LIMITED
Country of Origin -
India
Alternatives
Customer Also Bought
MRP
₹
119500
₹116150
2.8 % OFF
Quick Links
Related Blogs
Disclaimer
Medkart's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, medicines, generic alternatives, all possible side effects, drug interactions, warnings, alerts, lab tests, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
India's most trusted generic medicine pharmacy.
10 Lakh+
Happy customers
35000+
Pin-codes Covered
75 Lakh+
Orders Delivered
Authentic Products
All WHO-GMP Certified Medicines
About Medkart Pharmacy
Our Services
Follow Us On
Download the app for free
©2025 Medkart Pharmacy. All Rights Reserved